Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Current status of trypanosomiasis]

M Dumas1, B Bouteille

  • 1Travail de l'Institut d'Epidémiologie Neurologique et de Neurologie Tropicale, Faculté de Médecine, Limoges, France.

Medecine Tropicale : Revue Du Corps De Sante Colonial
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Etest ECVs/ECOFFs for Detection of Resistance in Prevalent and Three Nonprevalent <i>Candida</i> spp. to Triazoles and Amphotericin B and Aspergillus spp. to Caspofungin: Further Assessment of Modal Variability.

Antimicrobial agents and chemotherapy·2021
Same author

Antifungal susceptibility testing practices in mycology laboratories in France, 2018.

Journal de mycologie medicale·2020
Same author

Multicentre study to determine the Etest epidemiological cut-off values of antifungal drugs in Candida spp. and Aspergillus fumigatus species complex.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2019
Same author

[Epidemiology of cysticercosis and neurocysticercosis].

Medecine et sante tropicales·2014
Same author

[About an autochtonous case of neurocysticercosis in Mali].

Bulletin de la Societe de pathologie exotique (1990)·2009
Same author

[Neurology in developing countries].

Medecine tropicale : revue du Corps de sante colonial·2009
Same journal

[Physiopathology of chronic arthritis following chikungunya infection in man].

Medecine tropicale : revue du Corps de sante colonial·2012
Same journal

[Judicial or administrative settlement of medical malpractice claims. Update on medical liability].

Medecine tropicale : revue du Corps de sante colonial·2012
Same journal

[Chikungunya epidemic in 2005-2006: questions from occupational health professionals].

Medecine tropicale : revue du Corps de sante colonial·2012
Same journal

[Administrative issues linked to health insurance coverage of chronic post-chikungunya rheumatism].

Medecine tropicale : revue du Corps de sante colonial·2012
Same journal

[Coverage of the chikungunya epidemic on Reunion Island in 2006 by the French healthcare system].

Medecine tropicale : revue du Corps de sante colonial·2012
Same journal

[Five-year outcome of mother-to-child transmission of chikungunya virus].

Medecine tropicale : revue du Corps de sante colonial·2012
See all related articles

Sleeping sickness, or human African trypanosomiasis, is resurging due to socioeconomic issues. New diagnostic and therapeutic strategies are crucial for controlling this neglected tropical disease.

Area of Science:

  • Neuroscience
  • Parasitology
  • Immunology

Context:

  • Sleeping sickness (human African trypanosomiasis) is experiencing a resurgence, particularly in Africa, driven by socioeconomic challenges.
  • Current challenges include rising incidence, lack of rapid diagnostics, and limited availability of safe, effective treatments.
  • Understanding the pathogenesis of central nervous system (CNS) involvement is critical for effective disease management.

Purpose:

  • To highlight the urgent need for improved diagnostic criteria and therapeutic agents for sleeping sickness.
  • To emphasize the importance of mapping infected households for early patient identification and follow-up.
  • To discuss the ongoing research into novel methods for staging neurological involvement and potential vaccine development.

Summary:

Related Experiment Videos

  • The central nervous system (CNS) is affected when trypanosomes penetrate the blood-brain barrier, leading to characteristic sleeping sickness symptoms.
  • Determining CNS involvement is crucial for initiating treatment with toxic drugs like melarsoprol.
  • Research is exploring auto-antibodies against nervous system components as biomarkers for staging neurological involvement, showing promising results.

Impact:

  • Advances in understanding CNS pathogenesis offer hope for better control strategies.
  • Development of new diagnostic tools and less toxic treatments is essential to combat the disease effectively.
  • Future prospects include potential vaccine development and the introduction of novel drugs like nitroimidazoles, though progress is slow.